Literature DB >> 22396587

Coronary artery bypass graft: contemporary heart surgery center performance in China.

Shengshou Hu1, Zhe Zheng, Xin Yuan, Yun Wang, Sharon-Lise T Normand, Joseph S Ross, Harlan M Krumholz.   

Abstract

BACKGROUND: The use of coronary artery bypass grafting (CABG) surgery in China is growing, but little is known about hospital-level performance. We sought to characterize the variation in performance across hospitals participating in a national registry in China. METHODS AND
RESULTS: The study sample was drawn from the Chinese Cardiac Surgery Registry, a national multicenter database that includes 43 hospitals across 13 provinces and 4 direct-controlled municipalities in China. We assessed consecutive patients undergoing isolated CABG surgery during the period of January 1, 2007, through December 31, 2008. Hierarchical generalized linear models were used to estimate hospital-level risk-standardized in-hospital all-cause mortality rates (RSMR) and major complication rates (RSMCR), which included death, myocardial infarction, reoperation for bleeding, mediastinal infection, stroke, reintubation, and renal failure. Among 8739 patients who underwent isolated CABG surgery, the mean age was 62.2 years (SD=9.2), and 78% were male. Observed in-hospital mortality and complication rates were 2.2% (95% confidence interval [CI], 1.9-2.5%) and 6.6% (95% CI, 6.1-7.1%), respectively. The mean RSMR was 1.9% (SD=1.1), with a range of 0.7-5.8%, and the mean RSMCR was 6.4% (SD=1.5), with a range of 3.8-10.1%. The odds of dying and the odds of having a complication after CABG surgery at a hospital 1 SD below the average relative to a hospital 1 SD above the average were 2.06 (95% CI, 1.40-3.04) and 1.53 (95% CI, 1.31-1.79), respectively. The Eastern region had the lowest RSMR and RSMCR (1.6% and 5.8%, respectively), whereas the Central region had the highest RSMR (2.5%) and the Southern region had the highest RSMCR (7.7%).
CONCLUSIONS: Mortality and complication rates after CABG surgery in the Chinese Cardiac Surgery Registry are generally low but vary by hospital and region within China. These results suggest that there are opportunities to improve outcomes in some CABG facilities.

Entities:  

Mesh:

Year:  2012        PMID: 22396587      PMCID: PMC3509783          DOI: 10.1161/CIRCOUTCOMES.111.962365

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN: 1941-7713


  21 in total

1.  Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients.

Authors:  F Roques; S A Nashef; P Michel; E Gauducheau; C de Vincentiis; E Baudet; J Cortina; M David; A Faichney; F Gabrielle; E Gams; A Harjula; M T Jones; P P Pintor; R Salamon; L Thulin
Journal:  Eur J Cardiothorac Surg       Date:  1999-06       Impact factor: 4.191

Review 2.  Outcomes research: generating evidence for best practice and policies.

Authors:  Harlan M Krumholz
Journal:  Circulation       Date:  2008-07-15       Impact factor: 29.690

3.  Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism.

Authors:  Julia Steinberger; Stephen R Daniels; Robert H Eckel; Laura Hayman; Robert H Lustig; Brian McCrindle; Michele L Mietus-Snyder
Journal:  Circulation       Date:  2009-01-12       Impact factor: 29.690

4.  Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china.

Authors:  Andrew Moran; Dongfeng Gu; Dong Zhao; Pamela Coxson; Y Claire Wang; Chung-Shiuan Chen; Jing Liu; Jun Cheng; Kirsten Bibbins-Domingo; Yu-Ming Shen; Jiang He; Lee Goldman
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-05-04

5.  A decade of change--risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: a report from the STS National Database Committee and the Duke Clinical Research Institute. Society of Thoracic Surgeons.

Authors:  T Bruce Ferguson; Bradley G Hammill; Eric D Peterson; Elizabeth R DeLong; Frederick L Grover
Journal:  Ann Thorac Surg       Date:  2002-02       Impact factor: 4.330

6.  Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality.

Authors:  Elizabeth H Bradley; Jeph Herrin; Brian Elbel; Robert L McNamara; David J Magid; Brahmajee K Nallamothu; Yongfei Wang; Sharon-Lise T Normand; John A Spertus; Harlan M Krumholz
Journal:  JAMA       Date:  2006-07-05       Impact factor: 56.272

7.  Regional variation in patient risk factors and mortality after coronary artery bypass grafting.

Authors:  Jacquelyn A Quin; Shubin Sheng; Sean M O'Brien; Karl F Welke; Frederick L Grover; A Laurie Shroyer
Journal:  Ann Thorac Surg       Date:  2011-08-19       Impact factor: 4.330

8.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

9.  Strategies for reducing the door-to-balloon time in acute myocardial infarction.

Authors:  Elizabeth H Bradley; Jeph Herrin; Yongfei Wang; Barbara A Barton; Tashonna R Webster; Jennifer A Mattera; Sarah A Roumanis; Jeptha P Curtis; Brahmajee K Nallamothu; David J Magid; Robert L McNamara; Janet Parkosewich; Jerod M Loeb; Harlan M Krumholz
Journal:  N Engl J Med       Date:  2006-11-13       Impact factor: 91.245

10.  An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction.

Authors:  Harlan M Krumholz; Yun Wang; Jennifer A Mattera; Yongfei Wang; Lein Fang Han; Melvin J Ingber; Sheila Roman; Sharon-Lise T Normand
Journal:  Circulation       Date:  2006-03-20       Impact factor: 29.690

View more
  6 in total

1.  Trends in mortality and major complications for patients undergoing coronary artery bypass grafting among Urban Teaching Hospitals in China: 2004 to 2013.

Authors:  Xin Yuan; Heng Zhang; Zhe Zheng; Chenfei Rao; Yan Zhao; Yun Wang; Harlan M Krumholz; Shengshou Hu
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2017-10-01

2.  Comparing Outcomes of Coronary Artery Bypass Grafting Among Large Teaching and Urban Hospitals in China and the United States.

Authors:  Zhe Zheng; Heng Zhang; Xin Yuan; Chenfei Rao; Yan Zhao; Yun Wang; Sharon-Lise Normand; Harlan M Krumholz; Shengshou Hu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2017-06

Review 3.  Achieving best outcomes for patients with cardiovascular disease in China by enhancing the quality of medical care and establishing a learning health-care system.

Authors:  Lixin Jiang; Harlan M Krumholz; Xi Li; Jing Li; Shengshou Hu
Journal:  Lancet       Date:  2015-10-10       Impact factor: 79.321

4.  Clinical characteristics, outcomes and regional variations of acquired valvular heart disease patients undergoing cardiac surgery in China.

Authors:  Hongyuan Lin; Jianfeng Hou; Jiamiao Gong; Yongjian Wu; Zhe Zheng
Journal:  BMC Cardiovasc Disord       Date:  2022-04-21       Impact factor: 2.174

5.  The China Patient-Centred Evaluative Assessment of Cardiac Events (China PEACE)-Prospective Study of 3-Vessel Disease: rationale and design.

Authors:  Chenfei Rao; Tasce Bongiovanni; Xi Li; Huawei Gao; Heng Zhang; Jing Li; Yan Zhao; Xin Yuan; Kun Hua; Shengshou Hu; Harlan M Krumholz; Lixin Jiang; Zhe Zheng
Journal:  BMJ Open       Date:  2016-02-15       Impact factor: 2.692

6.  Comparison of the effects of coronary artery anastomosis training between senior and junior surgeons.

Authors:  Bo Li; Xiaokang Luo; Lei Qi; Dong Zhang; Fuliang Luo; Bin Li; Yue Tang
Journal:  Anatol J Cardiol       Date:  2020-09       Impact factor: 1.596

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.